Severity
Moderate
FDA Drug recall · Reported June 17, 2015
Labeling: incorrect or missing lot number and/or expiration date
Mallinckrodt, Inc. recalled MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organicall… - a moderate-severity action.
MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organicall… was recalled by Mallinckrodt, Inc. in June 17, 2015. Reason: Labeling: incorrect or missing lot number and/or expiration date. Check the official notice for the remedy. Verify recall #D-1132-2015 with the FDA Drug before acting.
The recall
Mallinckrodt, Inc. issued this moderate-severity FDA Drug recall-Labeling: incorrect or missing lot number and/or expiration date.
Sourced from official FDA Drug enforcement records. Verify recall #D-1132-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1132-2015) was formally reported on June 17, 2015, with the manufacturer initiating the action on May 15, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Mallinckrodt, Inc. is listed as the recalling firm, operating out of Hazelwood, MO. Federal records list the affected scope as 6600 bottles.
The documented reason for this recall is: Labeling: incorrect or missing lot number and/or expiration date Distribution data in the federal record shows the product reached: Costa Rica. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
6600 bottles
Related Recalls
6
5 from same agency
MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organically Bound Iodine For Gastrointestinal Radiography; Oral or rectal use only; Rx only; 30 mL; Single-Unit Container; ; Mallinckrodt Inc., St. Louis, MO 63042. NDC 0019-4816-04
Labeling: incorrect or missing lot number and/or expiration date
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1132-2015 |
| Date reported | June 17, 2015 |
| Date initiated | May 15, 2015 |
| Recalling firm | Mallinckrodt, Inc. |
| Firm location | Hazelwood, MO |
| Affected scope | 6600 bottles |
| Distribution | Costa Rica |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported June 17, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.